Lisa Olson
2023
In 2023, Lisa Olson earned a total compensation of $1.1M as Former Chief Scientific Officer at Dianthus Therapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $277,027 |
|---|---|
| Option Awards | $91,863 |
| Salary | $160,730 |
| Other | $598,393 |
| Total | $1,128,013 |
Olson received $598.4K in other compensation, accounting for 53% of the total pay in 2023.
Olson also received $277K in bonus, $91.9K in option awards and $160.7K in salary.
Rankings
In 2023, Lisa Olson's compensation ranked 1,082nd out of 3,006 executives tracked by ExecPay. In other words, Olson earned more than 64.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,082 out of 3,006 | 64th |
Division Manufacturing | 643 out of 1,650 | 61st |
Major group Chemicals And Allied Products | 439 out of 918 | 52nd |
Industry group Drugs | 428 out of 881 | 51st |
Industry Pharmaceutical Preparations | 292 out of 637 | 54th |
Source: SEC filing on April 11, 2024.
Olson's colleagues
We found six more compensation records of executives who worked with Lisa Olson at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
2023
Ryan Savitz
Dianthus Therapeutics